NS · Pharmaceuticals

Hester Biosciences Ltd (HESTERBIO)

Pharmaceuticals & Biotechnology

Hester Biosciences Ltd (HESTERBIO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-04, reported market cap is $17.95B, P/E ratio is 34.45, net margin is 12.6%, dividend yield is 0.52%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HESTERBIO

Market cap

$17.95B

P/E ratio

34.45

Net margin

12.6%

Dividend yield

0.52%

Hester Biosciences Ltd (HESTERBIO) — FAQ

What is Hester Biosciences Ltd's market cap?

Hester Biosciences Ltd (HESTERBIO) has a reported market cap of $17.95B (data as of 2026-07-04).

What is HESTERBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Hester Biosciences Ltd (HESTERBIO) is 34.45 (data as of 2026-07-04).

Does Hester Biosciences Ltd pay a dividend?

Hester Biosciences Ltd (HESTERBIO) shows a reported dividend yield of 0.52%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-04).

What sector is Hester Biosciences Ltd in?

Hester Biosciences Ltd (HESTERBIO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is HESTERBIO listed on?

HESTERBIO is listed on NS.

What is Hester Biosciences Ltd's net margin?

Hester Biosciences Ltd (HESTERBIO) reports a net margin of 12.6% (data as of 2026-07-04).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)